olmesartan has been researched along with cinanserin in 1 studies
| Studies (olmesartan) | Trials (olmesartan) | Recent Studies (post-2010) (olmesartan) | Studies (cinanserin) | Trials (cinanserin) | Recent Studies (post-2010) (cinanserin) |
|---|---|---|---|---|---|
| 841 | 185 | 554 | 245 | 12 | 46 |
| Protein | Taxonomy | olmesartan (IC50) | cinanserin (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.002 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 5 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 5 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.002 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.002 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.182 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foster, H; Foster, R; Philippou, H; Wilson, C | 1 |
1 other study(ies) available for olmesartan and cinanserin
| Article | Year |
|---|---|
Progress toward a Glycoprotein VI Modulator for the Treatment of Thrombosis.
Topics: Binding Sites; Biological Products; Humans; Ligands; Losartan; Molecular Dynamics Simulation; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Protein Kinase Inhibitors; Signal Transduction; Small Molecule Libraries; Thrombosis | 2020 |